Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

GSK rebrands AIDS drugs to foil illegal imports

March 2, 2005 Sales and Marketing

GlaxoSmithKline has rebranded its Aids drugs supplied to sub-Saharan Africa to stop illegal re-importation to Europe.The company said parallel importers …
News

Singulair gains dual asthma-hayfever indication

March 2, 2005 Sales and Marketing

Merck Sharpe & Dohme's blockbuster oral asthma treatment Singulair has received an expanded UK licence for the treatment of adult …
News

NHS is behind us, says rep-free Takeda

March 1, 2005 Sales and Marketing Davis, Takeda, sales and marketing

Takeda UK says new market research shows healthcare professionals and NHS managers are in favour of its revolutionary move away …
News

Cymbalta approved for second indication

February 24, 2005 Sales and Marketing

Cymbalta has received European approval for diabetic peripheral neuropathic pain (DPNP) in adults, with its marketers keen to meet what …
News

Sankyo and Daiichi set to continue Japanese consolidation

February 24, 2005 Sales and Marketing

Two of Japan's leading pharmaceutical companies Sankyo and Daiichi look set to merge later this year, accelerating consolidation in the …
News

Novartis becomes generic world leader

February 24, 2005 Sales and Marketing

News

FDA panel clears Vioxx return to market

February 21, 2005 Sales and Marketing

An FDA panel has narrowly voted in favour of allowing Vioxx to return to the market, after concluding it carries …
News

IMS and Innovex announce UK alliance

February 17, 2005 Sales and Marketing

Pharma data consultants IMS have announced a new alliance with contract sales provider Innovex to supply its field forces with …
News

Garnier hints at large-scale cutbacks to global salesforce

February 17, 2005 Sales and Marketing

News

ADHD latest drugs to be hit by safety warnings

February 17, 2005 Sales and Marketing

Attention deficit hyperactivity disorder (ADHD) treatments are the latest class of drugs to be hit by safety warnings, with regulators …
News

New FDA drug safety board to be more independent

February 17, 2005 Sales and Marketing

A new independent FDA board will be set up to monitor drug safety and issue warnings to doctors and patients …
News

Roche hepatitis and HIV combination approved

February 9, 2005 Sales and Marketing

Roche's Pegasys has become the first treatment licensed for patients suffering hepatitis C and HIV at the same time.The European …
News

Sanofi-Aventis sponsor cardiovascular research centre

February 9, 2005 Sales and Marketing

A new UK centre specialising in research into cardiovascular disease has opened its doors at St Mary's Hospital in Paddington, …
News

Schering launches new dermatology company

February 8, 2005 Sales and Marketing

German pharma company Schering has created a new, independent group, Intendis, focused on developing and marketing dermatology products.Intendis' new management …
News

Rare side-effect warnings for Strattera

February 8, 2005 Sales and Marketing

UK health professionals have been warned  about rare but serious liver problems observed in Lilly's Strattera.The drug has been licensed …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026